Optimizing your market access strategy

The following challenges always need to be addressed to recommend an appropriate Market Access Strategy

  • Patient

    What is the burden of disease and who are the patients likely to benefit the most from the incoming product ?
  • Treatment

    What is the standard of care for treatment of the pathology in the concerned countries ?
  • Studies

    How should clinical studies be designed in order to meet the methodological prerequisites per country, considering local HTA requirements ?
  • Benefits

    What are the benefits of the product in terms of efficacy, safety, convenience of use in comparison to current and upcoming therapeutic alternatives ?
  • Opportunity

    Is there an opportunity for an early access program ?
  • Pricing

    What can be expected in terms of added economic value vs. current treatments ?
  • Negotiation

    What are the pricing scenarios and likelihood of reimbursement ?

AEC Partners can help you optimize your market access strategy

The main challenge today is to evaluate the added medical value that a new product must demonstrate to ensure a successful price and reimbursement negotiation.

We propose to conduct a structured and methodological approach that will clearly define :

  • current requirements for success in EU 5
  • most appropriate market access strategy and action plan for HTA assessment and pricing negotiation.
  • At European (EU5)

    • Maximize product chances of success by integrating market access levers during early development (phase 1 et 2)
    • Based on our European expert network, define, test and validate your market access strategies upstream (Willingness to Use and Willingness to Pay)
    • Develop the Payer Value Proposition
  • Or local level

    • Challenge and validate sales forecasts based on epidemiology and market modelling
    • Perform, support or audit the market access strategy, dossiers for HTA bodies and the negotiation approach
    • Assist through the whole negotiation phase at a local level

Why choose AEC Partners

  • Successful bottom-up approach with senior experts and a dedicated team
    • Highly experienced and dedicated team for market access activities
    • A systematic senior presence at every phase of the project
    • Start with local issues to find tailored solution at a European level
    • Analytical and pragmatic approach
  • Strong experience in defining market access strategies
    • More than 300 assignments supporting big, mid-size pharma and medical device companies in market access strategies
    • Trained to manage complex situations
    • Strong expertise in orphan and onco-hematology products
  • Local implementation and assistance through the whole negotiation process
    • From European strategy to local dossier writing and submission (including logistics)
    • Deep knowledge regarding payers expectations
    • Assistance from early access program to P&R deal with local authorities